Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
Clinical trial NCT00840684 · COMPLETED
Trial details
- NCT number
- NCT00840684
- Sponsor
- Institut Paoli-Calmettes
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-05-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.